DDX3-IN-2
CAS No. 1919828-81-1
DDX3-IN-2 ( —— )
产品货号. M35526 CAS No. 1919828-81-1
DDX3-IN-2 是一种活性 DEADbox polypeptide 3 (DDX3) 抑制剂,其 IC50 值 0.3 μM。DDX3-IN-2 表现出广谱的抗病毒活性。DDX3-IN-2 有克服 HIV 耐药的潜力。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称DDX3-IN-2
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述DDX3-IN-2 是一种活性 DEADbox polypeptide 3 (DDX3) 抑制剂,其 IC50 值 0.3 μM。DDX3-IN-2 表现出广谱的抗病毒活性。DDX3-IN-2 有克服 HIV 耐药的潜力。
-
产品描述DDX3-IN-2 is an active DEADbox polypeptide 3 (DDX3) inhibitor with an IC50 value of 0.3 μM. DDX3-IN-2 shows a broad spectrum of antiviral activity. DDX3-IN-2 has the potential to overcome HIV resistance.
-
体外实验DDX3-IN-2 behaves as a competitive inhibitor with respect to the RNA substrate, which can be seen by the decrease in its inhibition potency as a function of increasing RNA substrate concentrations. DDX3-IN-2 is found to be completely inactive against the ATPase of DDX3, DDX1 helicase, and DENV NS3 helicase.
-
体内实验DDX3-IN-2 (20 mg/kg; tail vein injection) possesses excellent biocompatibility, and Wistar rats shows a good tolerance to the dose of 20 mg/kg.DDX3-IN-2 (10 mg/kg; i.v. bolus injection; 0~25 hours) rapidly eliminates the half-life elimination and the plasmatic clearance values.Animal Model:Wistar rats Dosage:Tail vein injection Administration:20 mg/kg Result:Possessed excellent biocompatibility, and Wistar rats showed a good tolerance to the dose of 20 mg/kg.Animal Model:Rats Dosage:I.v. bolus injection (Pharmacokinetic Analysis) Administration:10 mg/kg; 0~25 hours Result:Rapidly eliminated the half-life elimination and the plasmatic clearance values.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number1919828-81-1
-
分子量349.43
-
分子式C20H23N5O
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 100 mg/mL (286.18 mM; 超声助溶 )
-
SMILESCCCCc1cn(nn1)-c1ccc(NC(=O)Nc2ccccc2C)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Brai A, et al. Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents. Proc Natl Acad Sci U S A. 2016;113(19):5388-5393.?
产品手册
关联产品
-
BNTA
BNTA 是一种有效的细胞外基质 (ECM) 调节剂,通过激活超氧化物歧化酶 3 (SOD3) 促进软骨细胞上软骨结构分子的合成。BNTA 通过调节软骨生成显示了一种有希望的缓解骨关节炎的潜力。
-
Anticancer agent 46
Anticancer agent 46 (compound 2) 是一种有效的抗癌剂。Anticancer agent 46 显示出抗增殖活性,对 MGC803 细胞的 IC50 为 0.986 μM。Anticancer agent 46 具有胃癌研究潜力。
-
Jatrorrhizine hydroc...
Jatrorrhizine?chloride 是从黄连中分离得到的生物碱,具有神经保护、抗菌、抗疟原虫和抗氧化活性。Jatrorrhizine?chloride 是有效的,具有口服活性的乙酰胆碱酯酶 (AChE) (IC50=872 nM) 的抑制剂,是对 BuChE 的选择性为 115 倍。Jatrorrhizine?chloride 通过抑制 uptake-2 transporter 的活性减少血清素 (5-HT) 和去甲肾上腺素 (NE) 的摄取。
021-51111890
购物车()
sales@molnova.cn

